Intel got a reprieve from the European Courts of Justice (ECJ), when Europe’s top court Wednesday backed an appeal against a massive fine imposed by the bloc’s antitrust regulator.
The ruling could have implications for Alphabet’s Google and Apple which are also facing large fines from Europe.
The European Commission’s antitrust regulator in 2009 fined Intel a record-breaking (at the time) €1.06 billion (US$1.26 billion) fine for having abused its dominant position for x86 central processing units by implementing a strategy aimed at pushing competitor Advanced Micro Devices (AMD) out of the market.
The regulator said Intel broke EU competition rules when it granted rebated to major computer manufacturers – Dell, Lenovo, HP and NEC – on the condition that they purchased all their x86 CPUs from Intel, thus diminishing the ability of competitors to compete.
Intel appealed the fine in 2014, but the General Court dismissed the action. The tech company then brought an appeal against the General Court’s judgment before the Court of Justice.
The ECJ on Wednesday, September 6, said the General Court failed to examine all the evidence presented in the appeal, concerning the alleged errors made by the commission in their initial ruling.
“The Court therefore sets aside the judgment of the General Court as a result of that failure in its analysis of whether the rebates at issue were capable of restricting competition,” the ECJ said. “The Court refers the case back to the General Court so that it may examine, in the light of the arguments put forward by Intel, whether the rebates at issue are capable of restricting competition.”
Full Content: InfoCuria & New York Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas